1.8006
price down icon7.20%   -0.1396
 
loading
전일 마감가:
$1.9402
열려 있는:
$1.96
하루 거래량:
31,500
Relative Volume:
0.26
시가총액:
$4.18M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.1417
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
+17.17%
1개월 성능:
+23.99%
6개월 성능:
-11.30%
1년 성능:
-47.81%
1일 변동 폭
Value
$1.73
$1.96
1주일 범위
Value
$1.53
$1.96
52주 변동 폭
Value
$0.952
$6.39

Tharimmune Inc Stock (THAR) Company Profile

Name
명칭
Tharimmune Inc
Name
전화
302-743-2995
Name
주소
1200 ROUTE 22 EAST, BRIDGEWATER
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-08-05
Name
최신 SEC 제출 서류
Name
THAR's Discussions on Twitter

THAR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
THAR
Tharimmune Inc
1.8006 4.18M 0 -9.32M -7.30M -12.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
539.21 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.43 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
552.88 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.02 28.51B 3.81B -644.79M -669.77M -6.24

Tharimmune Inc 주식(THAR)의 최신 뉴스

pulisher
Jun 18, 2025

Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors - The Holland Sentinel

Jun 18, 2025
pulisher
Jun 17, 2025

EON Resources Inc. Announcement - Worcester Telegram

Jun 17, 2025
pulisher
Jun 17, 2025

AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - Lubbock Avalanche-Journal

Jun 17, 2025
pulisher
Jun 17, 2025

Tharimmune announces key leadership changes to advance pipeline - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Navy SEAL Commander Joins Biotech Developing Military Defense Against Weaponized Fentanyl - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

Don Kim Resigns as CFO of Tharimmune effective immediatelySEC filing - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Interactive Strength Inc. (Nasdaq:TRNR) Closes Initial $55 Million Investment for Crypto Treasury Strategy and Begins Acquiring $FET - Lohud

Jun 16, 2025
pulisher
Jun 12, 2025

Hawley Crescent Catering & Events Wins 2025 Consumer Choice Award for Catering Excellence in Durham Region - Cincinnati Enquirer

Jun 12, 2025
pulisher
Jun 11, 2025

Tharimmune announces executive changes and new agreements - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Tharimmune announces executive changes and new agreements By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

TharimmuneRandy Milby Resigns As CEO And Board Member - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025 - IndyStar

Jun 11, 2025
pulisher
Jun 10, 2025

Tharimmune Holds Annual Meeting, Elects Directors - TipRanks

Jun 10, 2025
pulisher
May 19, 2025

Tharimmune (THAR) Appoints Strategic Advisor to Enhance TH104 De - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback - Jonesboro Sun

May 19, 2025
pulisher
May 19, 2025

FDA Clears Path for Tharimmune's Military Fentanyl Defense Drug as Navy SEAL Commander Joins Advisory Team - Stock Titan

May 19, 2025
pulisher
May 12, 2025

Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Tharimmune, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 10, 2025

Tharimmune appoints new executive chairman By Investing.com - Investing.com India

May 10, 2025
pulisher
May 10, 2025

Tharimmune appoints new executive chairman - Investing.com Australia

May 10, 2025
pulisher
May 09, 2025

Tharimmune IncAppoints Vincent Lopriore As Executive ChairmanSEC Filing - marketscreener.com

May 09, 2025
pulisher
May 06, 2025

Tharimmune (THAR) Reports Promising Phase 1 Results for TH104 Bu - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Tharimmune (THAR) Advances TH104 as Key Medical Countermeasure | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Tharimmune advances opioid prophylaxis drug TH104 - Investing.com

May 06, 2025
pulisher
May 06, 2025

Tharimmune advances opioid prophylaxis drug TH104 By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback - Weatherford Democrat

May 06, 2025
pulisher
May 06, 2025

Tharimmune's New Drug Breakthrough: FDA Fast-Tracks Military Protection Against Weaponized Fentanyl - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences - Chronicle-Tribune

May 05, 2025
pulisher
May 03, 2025

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors - Bluefield Daily Telegraph

May 03, 2025
pulisher
May 01, 2025

Stocks of Tharimmune Inc (THAR) are poised to climb above their peers - Sete News

May 01, 2025
pulisher
May 01, 2025

Breakthrough Drug TH104 Clinical Data Selected for Two Premier Medical Conferences DDW and EASL - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

Tharimmune Appoints Clay Kahler And Gary Stetz To Board - citybiz

Apr 30, 2025
pulisher
Apr 30, 2025

Tharimmune (THAR) Expands Board with New Appointments | THAR Sto - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Tharimmune expands board with two new directors By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

Tharimmune expands board with two new directors - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Tharimmune Adds $500M Success Story Entrepreneur and Financial Expert to Board Leadership - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

Tharimmune Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Tharimmune Inc (THAR) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

These Numbers Show Just How Powerful Tharimmune Inc (NASDAQ: THAR) Stock ‎Is - Stocksregister

Apr 29, 2025
pulisher
Apr 29, 2025

Tharimmune expands board, appoints new directors By Investing.com - Investing.com Nigeria

Apr 29, 2025
pulisher
Apr 29, 2025

Tharimmune expands board, appoints new directors - Investing.com

Apr 29, 2025
pulisher
Apr 28, 2025

FDA Nods to Tharimmune’s Countermeasure for Opioid Threats By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

FDA Nods to Tharimmune’s Countermeasure for Opioid Threats - Investing.com Australia

Apr 28, 2025
pulisher
Apr 28, 2025

Now Is The Time To Build A Position In Tharimmune Inc (NASDAQ:THAR) - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

Observations on the Tharimmune Inc (NASDAQ:THAR) Growth Curve - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Tharimmune (THAR) Advances TH104 with FDA Feedback on New Drug A - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Tharimmune (THAR) Advances TH104 with FDA Feedback on New Drug Application | THAR Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback - The Joplin Globe

Apr 28, 2025
pulisher
Apr 28, 2025

FDA Clears Path for Tharimmune's Military-Grade Fentanyl Defense Drug: No New Trials Needed - Stock Titan

Apr 28, 2025

Tharimmune Inc (THAR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Tharimmune Inc 주식 (THAR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Parikh Sanam
Director
Jun 20 '25
Buy
1.45
1,000
1,450
1,770
Appajosyula Sireesh
Chief Executive Officer
Jun 20 '25
Buy
1.48
61,496
90,973
64,868
Parikh Sanam
Director
May 15 '25
Buy
1.30
770
1,001
770
MILBY RANDY
CEO
Dec 19 '24
Buy
2.12
4,600
9,752
17,534
Appajosyula Sireesh
Chief Operating Officer
Nov 13 '24
Buy
2.02
5,000
10,096
10,758
MILBY RANDY
CEO
Oct 08 '24
Buy
2.09
2,500
5,221
12,934
Appajosyula Sireesh
Chief Operating Officer
Oct 08 '24
Buy
1.93
5,000
9,650
16,364
$20.90
price up icon 1.31%
$35.76
price down icon 0.62%
$21.32
price down icon 0.15%
$98.61
price down icon 1.98%
$108.80
price up icon 2.21%
biotechnology ONC
$246.51
price up icon 1.76%
자본화:     |  볼륨(24시간):